Dr. Krishna Chaitanya Mylavarapu, MD

Dr. Mylavarapu practices at St. Bernards Medical Center in Jonesboro, Arkansas, part of St. Bernards Healthcare.

Dr. Mylavarapu's NPI, 1275889198, was assigned on July 29, 2012. Dr. Mylavarapu holds Arkansas license E-8399.

Dr. Mylavarapu's primary practice is St. Bernards Medical Center, at 225 E Washington Ave, Jonesboro, AR 72401 in Craighead County. The practice phone is (870) 972-4100.

Dr. Mylavarapu's primary practice is St. Bernards Medical Center in Jonesboro, Arkansas, part of St. Bernards Healthcare. Dr. Mylavarapu is also affiliated with NEA Baptist Memorial Hospital. The medical group on file is St. Bernards Healthcare. Dmand AI also links Dr. Mylavarapu to 2 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mylavarapu practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mylavarapu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mylavarapu is licensed in Arkansas.

CMS data shows 385 Medicare services from Dr. Mylavarapu across 8 procedure codes in 2024, for 237 Medicare patients. Medicare paid $27,197 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Mylavarapu in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mylavarapu's median patient age at 61, with 59% women.

In 2024, Dr. Mylavarapu wrote 155 Medicare Part D claims for 50 patients. 88% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $794 in total drug cost. In 2023, CMS named 680 claims across 27 drugs.

Dr. Mylavarapu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mylavarapu as offering telehealth.

Dmand AI links 3 papers to Dr. Mylavarapu, published from 2011 to 2014. 2011 was the busiest year, with 2. Dr. Mylavarapu's most frequent co-authors are Klara Briskin, MD, Marcus Ronald Chacon, MD and Tanvi N. Nadkarni.

CMS Open Payments shows 700 general payments to Dr. Mylavarapu from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,514.